Cardiology Clinical Trials in Birmingham, AL
As of August 2026, 41 paid clinical trials are recruiting for Cardiology in Birmingham, Alabama. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Birmingham
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
42 clinical trials for Cardiology
·Clear filters·A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Assessment of CCM in HF With Higher Ejection Fraction
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Prevail Global Study
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Therapeutic Mechanisms of Epidural Spinal Cord Stimulation
Early Time-Restricted Eating in Older Adults With Hypertension
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Arterial Stiffness and Blood Pressure
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
CARBON: UAB Cardiovascular Research Biobank
Inspire HER: Inspiring the Heart and Emotions for Radical Health
Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Top Research Study Locations in Birmingham
Researchers run research studies in Birmingham, AL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Alabama at Birmingham | Hypertension, Cancer, Cardiovascular Diseases | 345 |
| Children's Hospital of Alabama | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 36 |
| University of Alabama at Birmingham Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma | 33 |
| University of Alabama | Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM) | 31 |
| University of Alabama Birmingham | Amyotrophic Lateral Sclerosis, AML (Acute Myelogenous Leukemia), Acetabulum Fractures | 29 |
| The University of Alabama at Birmingham | Idiopathic Pulmonary Fibrosis, ALK-positive Histiocytosis, Advanced or Metastatic Solid Tumors | 28 |
| UAB | Opioid Overdose, Opioid Use Disorder, Alzheimer Disease | 15 |
| Children's of Alabama | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Bowel Incontinence | 15 |
| University of Alabama Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 13 |
| Birmingham VA Medical Center, Birmingham, AL | Adult Growth Hormone Deficiency, Aging, Carcinoma, Hepatocellular | 11 |
| University of Alabama - Birmingham | Obstetrical Complications, CPPD - Calcium Pyrophosphate Deposition Disease, Cesarean Delivery | 7 |
| Alabama Oncology | Non-Small Cell Lung Cancer, Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer | 6 |
| University of Alabama At Birmingham Hospital | Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma | 6 |
| University of Alabama, Birmingham | Acute Porphyrias, Alzheimer's Disease (AD), Bone Marrow Transplant (BMT) | 6 |
| Central Alabama Research | Colorectal Cancer, Early Breast Cancer, Influenza | 5 |
| Central Research Associates | Chronic Pain, Osteoarthritis, Knee, Chronic Low-back Pain | 5 |
| University of Alabama in Birmingham | Alzheimers Disease, Alzheimers Disease, Familial, Dementia | 5 |
| AllerVie Clinical Research | Atopic, Atopic Dermatitis, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 5 |
| Clinical Trial Site | Acute Hepatic Porphyria, Generalized Myasthenia Gravis, High Cardiovascular Risk | 4 |
| Alabama Clinical Therapeutics | Degenerative Disc Disease, Degenerative Disc Disease (DDD), Growth | 4 |
| Birmingham Clinical Research | Obesity, Overweight, Atherosclerotic Cardiovascular Disease (ASCVD) | 4 |
| O'Neal Comprehensive Cancer Center at UAB | Advanced Lung Carcinoma, Carcinoma, Endometrial Cancer | 4 |
| The Children's Hospital Alabama, University of Alabama at Birmingham | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| The Kirklin Clinic | Breast Cancer, Breast Neoplasm, Cancer | 4 |
| The Kirklin Clinic of UAB Hospital | Advanced or Metastatic Solid Tumors, Brain Neoplasms, Cachexia | 4 |
Active & Upcoming Studies in Birmingham (2026)
Recruiting trials in Birmingham grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (231 active studies)
- Developing Pilot Postoperative Guidelines for Improved Functional Outcomes After High-Risk Cancer Surgery · University of Alabama at Birmingham
- Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) · EARLY_Phase 1 · University of Alabama at Birmingham
Cardiovascular (64 active studies)
- Monitoring Blood Pressure at Home and Pharmacy Telehealth · University of Alabama at Birmingham
- Feasibility and Acceptability of Three Component Intervention for the Heart Failure Care for Rural Dwelling Participants · University of Alabama at Birmingham
Diabetes & metabolic (63 active studies)
- MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients · University of Alabama at Birmingham
- Semaglutide for Low Back Pain · Phase 2 · Washington University School of Medicine
Neurology & pain (57 active studies)
- Semaglutide for Low Back Pain · Phase 2 · Washington University School of Medicine
- Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · University of Alabama at Birmingham
Pediatric (24 active studies)
- Cue-Based Vs. Clinician-Driven Feeding in Very Low Birthweight Infants · University of Alabama at Birmingham
- Application to Predict Neonatal Apnea With Bradycardia · University of Alabama at Birmingham
HIV / STI (21 active studies)
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Mental health & behavior (21 active studies)
- Mobile Thinking Intervention: A Inital Test · University of Alabama at Birmingham
- A Cognitive Mobile Intervention for Motivation in Psychotic Disorders · Phase 1, Phase 2 · University of Alabama at Birmingham
Vaccines (12 active studies)
- How Healthy Adults Respond to the Nasal Flu Vaccine · Phase 4 · University of Alabama at Birmingham
- Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines · Phase 4 · University of Alabama at Birmingham
Eye & vision (5 active studies)
- Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine. · Phase 2 · University of Alabama at Birmingham
- Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema · Phase 1 · University of Alabama at Birmingham
Common conditions studied in Birmingham
- Obesity (21 active studies)
- Breast Cancer (15 active studies)
- Hypertension (13 active studies)
- Multiple Myeloma (13 active studies)
- Cancer (12 active studies)
- Ovarian Cancer (12 active studies)
Leading research sponsors in Birmingham
- University of Alabama at Birmingham
- National Cancer Institute (NCI)
- Children's Oncology Group
- Eli Lilly and Company
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Birmingham?
There are approximately 1,003 recruiting clinical trials in Birmingham, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Birmingham pay participants?
Most recruiting trials in Birmingham compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Birmingham?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Birmingham?
The most common conditions under active study in Birmingham include Obesity (21), Breast Cancer (15), Hypertension (13), Multiple Myeloma (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Birmingham?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Birmingham on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Birmingham?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Birmingham?
Recruiting research sites in Birmingham include University of Alabama at Birmingham, Children's Hospital of Alabama, University of Alabama at Birmingham Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Birmingham right now?
The largest active categories in Birmingham are Cancer & tumors (231), Cardiovascular (64), Diabetes & metabolic (63). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.